DAYLI Partners
Seoul, Seouldayli.partners
Overview
DAYLI Partners is a venture capital firm in South Korea that specializes in venture investments in the pharmaceutical, healthcare, and biotechnology sectors . The firm creates sustainable value by spearheading industry evolution and innovation .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BreezeBio | Feb 2026 | Series B | Co-investor |
| Galux | Feb 2026 | Series B | Co-investor |
| 1ST Biotherapeutics, Inc. | Jan 2026 | Series D | Co-investor |
| Illimis Therapeutics | Jul 2025 | Series B | Co-investor |
| SeaWith Inc. | Oct 2024 | Series A Extension | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.